UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription

Cell death & disease, 2016-07, Vol.7 (7), p.e2297-e2297

2016

Volltextzugriff (PDF)

A study of pyrimidine base damage in relation to oxidative stress and cancer

British journal of cancer, 2009-08, Vol.101 (3), p.452-456

2009

Volltextzugriff (PDF)

Consumption of black tea or coffee and risk of ovarian cancer

International journal of gynecological cancer, 2007-01, Vol.17 (1), p.50-54

2007

Volltextzugriff (PDF)

Active and passive smoking and risk of ovarian cancer

International journal of gynecological cancer, 2006-02, Vol.16 (S1), p.211-218

2006

Volltextzugriff (PDF)

The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus

Histopathology, 2008-10, Vol.53 (4), p.490-495

2008

Volltextzugriff (PDF)

High Distant Failure Rate Despite Good Local Control in High Risk Early Stage Endometrial Cancer

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S366-S366

2008

Volltextzugriff (PDF)

Primary fallopian tube carcinoma: a retrospective clinicopathologic study

European journal of gynaecological oncology, 2006, Vol.27 (1), p.16-18

2006

Volltextzugriff (PDF)

A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas

Oncogene, 1998-01, Vol.16 (4), p.555-559

1998

Volltextzugriff (PDF)

Antioxidant inhibits tamoxifen–DNA adducts in endometrial explant culture

Biochemical and biophysical research communications, 2003-07, Vol.307 (1), p.157-164

2003

Volltextzugriff (PDF)

191P Preliminary biomarker and safety results of SQZ-PBMC-HPV at RP2D in monotherapy and combination with checkpoint inhibitors in HLA A02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors

Immuno-oncology technology, 2022-12, Vol.16, p.100303, Article 100303

2022

Volltextzugriff (PDF)

Active and passive smoking and risk of ovarian cancer

International journal of gynecological cancer, 2006-01, Vol.16 (Suppl 1), p.211-218

2006

Volltextzugriff (PDF)

000280 OUTCOME OF PATIENTS WITH MUCINOUS OVARIAN CARCINOMA

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.129-129

2005

Volltextzugriff (PDF)

Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors

Cancer research (Chicago, Ill.), 1995-05, Vol.55 (10), p.2169-2172

1995

Volltextzugriff (PDF)

Custody Planning: A Retrospective Review of Oncology Patients Who Were Single Parents

Journal of pain and symptom management, 2001-05, Vol.21 (5), p.380-384

2001

Volltextzugriff (PDF)

Prospective analysis of chemotherapy-induced neuropathy in patients with gynecologic malignancies

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e19737-e19737

2011

Volltextzugriff (PDF)

Breast Cancer Prevention

Clinical obstetrics and gynecology, 2001-09, Vol.44 (3), p.478-484

2001

Volltextzugriff (PDF)

Venous thromboembolism in ovarian cancer patients receiving erythropoietin (Epo)/darbepoetin (Darbe) for chemotherapy-induced anemia (CIA)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16514-16514

2008

Volltextzugriff (PDF)

A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer

Gynecologic oncology, 2005-10, Vol.99 (1), p.183-188

2005

Volltextzugriff (PDF)

A phase II, pharmacokinetic (PK), and pharmacodynamic (PD) study of weekly docetaxel (DOC) in patients with platinum-resistant ovarian cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e16531-e16531

2009

Volltextzugriff (PDF)

Limited value of routine iron studies prior to initiation of erythropoietin therapy in patients with ovarian cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.19677-19677

2007

Volltextzugriff (PDF)

Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors

Oncogene, 1995-10, Vol.11 (7), p.1249-1254

1995

Volltextzugriff (PDF)

Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma

Gynecologic oncology, 2004-12, Vol.95 (3), p.539-545

2004

Volltextzugriff (PDF)

Natural history of postterm choriocarcinoma

Journal of reproductive medicine, 1998-01, Vol.43 (1), p.75

1998

Volltextzugriff (PDF)

Regular Analgesic Use and Risk of Endometrial Cancer

Cancer epidemiology, biomarkers & prevention, 2005-12, Vol.14 (12), p.2923-2928

2005

Volltextzugriff (PDF)

The role of hereditary nonpolyposis colorectal cancer in the management of familial ovarian cancer

Genetics in medicine, 2006-10, Vol.8 (10), p.653-657

2006

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(52)
Reviews
(1)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription

A study of pyrimidine base damage in relation to oxidative stress and cancer

Consumption of black tea or coffee and risk of ovarian cancer

Active and passive smoking and risk of ovarian cancer

The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus

High Distant Failure Rate Despite Good Local Control in High Risk Early Stage Endometrial Cancer

Primary fallopian tube carcinoma: a retrospective clinicopathologic study

A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas

Antioxidant inhibits tamoxifen–DNA adducts in endometrial explant culture

191P Preliminary biomarker and safety results of SQZ-PBMC-HPV at RP2D in monotherapy and combination with checkpoint inhibitors in HLA A02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors

Active and passive smoking and risk of ovarian cancer

000280 OUTCOME OF PATIENTS WITH MUCINOUS OVARIAN CARCINOMA

Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors

Custody Planning: A Retrospective Review of Oncology Patients Who Were Single Parents

Prospective analysis of chemotherapy-induced neuropathy in patients with gynecologic malignancies

Breast Cancer Prevention

Venous thromboembolism in ovarian cancer patients receiving erythropoietin (Epo)/darbepoetin (Darbe) for chemotherapy-induced anemia (CIA)

A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer

A phase II, pharmacokinetic (PK), and pharmacodynamic (PD) study of weekly docetaxel (DOC) in patients with platinum-resistant ovarian cancer

Limited value of routine iron studies prior to initiation of erythropoietin therapy in patients with ovarian cancer

Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors

Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma

Natural history of postterm choriocarcinoma

Regular Analgesic Use and Risk of Endometrial Cancer

The role of hereditary nonpolyposis colorectal cancer in the management of familial ovarian cancer

Suchergebnisse filtern